{
    "eid": "2-s2.0-85125154060",
    "title": "The sterility, stability and efficacy of repackaged ziv-aflibercept for intravitreal administration",
    "cover-date": "2022-12-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Multidisciplinary",
            "@code": "1000",
            "@abbrev": "MULT"
        }
    ],
    "keywords": [],
    "authors": [
        "Jakkrit Juhong",
        "Pear Ferreira Pongsachareonnont",
        "Thanapong Somkijrungroj",
        "Apivat Mavichak",
        "Adisai Varadisai",
        "Pajaree Chariyavilaskul",
        "Tanittha Chatsuwan",
        "Thitima Benjachat Suttichet",
        "Kittisak Kulvichit"
    ],
    "citedby-count": 1,
    "ref-count": 28,
    "ref-list": [
        "Angiogenesis and eye disease",
        "Age-related macular degeneration: Pathogenesis, genetic background, and the role of nutritional supplements",
        "Normalization of the vasculature for treatment of cancer and other diseases",
        "Ocular neovascularization: Basic mechanisms and therapeutic advances",
        "Anti-vascular endothelial growth factor for neovascular age-related macular degeneration",
        "Aflibercept: A review of its use in the treatment of choroidal neovascularization due to age-related macular degeneration",
        "VEGF-Trap: A VEGF blocker with potent antitumor effects",
        "Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration",
        "Aflibercept, bevacizumab or ranibizumab for diabetic macular oedema: Recent clinically relevant findings from DRCR.net Protocol T",
        "Intravitreal aflibercept and ranibizumab injections for polypoidal choroidal vasculopathy",
        "Ziv-aflibercept in macular disease",
        "Safety profiles of anti-VEGF drugs: Bevacizumab, ranibizumab, aflibercept and ziv-aflibercept on human retinal pigment epithelium cells in culture",
        "Short-term safety profile of intravitreal ziv-aflibercept",
        "Long-term safety and efficacy of ziv-aflibercept in retinal diseases",
        "Ziv-aflibercept: A cost-effective, off-label, highly potent antagonist of vascular endothelial growth factor",
        "Intravitreal injections of ziv-aflibercept for diabetic macular edema: a pilot study",
        "Evaluation of aflibercept and ziv-aflibercept binding affinity to vascular endothelial growth factor, stability and sterility after compounding",
        "Review of the 2008 European Medicines Agency concept paper on bioanalytical method validation",
        "Intravitreal Ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: 5-year randomized trial results",
        "Intravitreal bevacizumab: safety of multiple doses from a single vial for consecutive patients",
        "Evaluation of the sterility, stability, and efficacy of bevacizumab stored in multiple-dose vials for 6 months",
        "Evaluation of compounded bevacizumab prepared for intravitreal injection",
        "Bevacizumab sterility in multiple doses from a single-use vial",
        "Storage stability of bevacizumab in polycarbonate and polypropylene syringes",
        "Quantification, microbial contamination, physico-chemical stability of repackaged bevacizumab stored under different conditions",
        "Long-term in vitro functional stability of compounded ranibizumab and aflibercept",
        "Pharmaceutical compounding of aflibercept in prefilled syringes does not affect structural integrity, stability or VEGF and Fc binding properties"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": []
}